RS62375B1 - Čestice polimera i njihova upotreba - Google Patents

Čestice polimera i njihova upotreba

Info

Publication number
RS62375B1
RS62375B1 RS20211112A RSP20211112A RS62375B1 RS 62375 B1 RS62375 B1 RS 62375B1 RS 20211112 A RS20211112 A RS 20211112A RS P20211112 A RSP20211112 A RS P20211112A RS 62375 B1 RS62375 B1 RS 62375B1
Authority
RS
Serbia
Prior art keywords
polymer particles
particles
polymer
Prior art date
Application number
RS20211112A
Other languages
English (en)
Inventor
Bernd Helmut Adam Rehm
Original Assignee
Polybatics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polybatics Ltd filed Critical Polybatics Ltd
Publication of RS62375B1 publication Critical patent/RS62375B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51Lyases (4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866Interferon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/555Interferons [IFN]
    • G01N2333/57IFN-gamma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
RS20211112A 2014-02-04 2015-02-04 Čestice polimera i njihova upotreba RS62375B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ62068214 2014-02-04
PCT/NZ2015/050008 WO2015119512A1 (en) 2014-02-04 2015-02-04 Polymer particles and uses thereof
EP15746012.2A EP3102613B1 (en) 2014-02-04 2015-02-04 Polymer particles and uses thereof

Publications (1)

Publication Number Publication Date
RS62375B1 true RS62375B1 (sr) 2021-10-29

Family

ID=53778236

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20211112A RS62375B1 (sr) 2014-02-04 2015-02-04 Čestice polimera i njihova upotreba

Country Status (13)

Country Link
US (1) US10501505B2 (sr)
EP (1) EP3102613B1 (sr)
CY (1) CY1124491T1 (sr)
DK (1) DK3102613T3 (sr)
ES (1) ES2891973T3 (sr)
HK (1) HK1232241A1 (sr)
HR (1) HRP20211418T1 (sr)
HU (1) HUE056108T2 (sr)
LT (1) LT3102613T (sr)
PL (1) PL3102613T3 (sr)
RS (1) RS62375B1 (sr)
SI (1) SI3102613T1 (sr)
WO (1) WO2015119512A1 (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2950436T3 (es) 2016-12-14 2023-10-10 Becton Dickinson Co Métodos y composiciones para obtener una valoración de tuberculosis en un sujeto
CN109776662B (zh) * 2019-03-13 2022-05-17 中国动物卫生与流行病学中心 一种用于牛结核病变态反应检测的鸡尾酒抗原
CN109776661B (zh) * 2019-03-13 2022-08-09 中国动物卫生与流行病学中心 一种牛结核病γ-干扰素ELISA检测用鸡尾酒刺激抗原
CN109813576B (zh) * 2019-03-25 2021-04-02 中国动物卫生与流行病学中心 一种牛结核病刺激上清制备用采血器
CN109813884A (zh) * 2019-03-25 2019-05-28 中国动物卫生与流行病学中心 一种牛结核病γ-干扰素快速检测制品
CN111269297B (zh) * 2020-01-23 2021-11-30 郑州伊美诺生物技术有限公司 一种结核分枝杆菌刺激抗原的制备方法
EP4132952A2 (en) * 2020-04-08 2023-02-15 Nanopin Technologies, Inc. Monoclonal antibodies and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722840A (en) * 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US20060024332A1 (en) 2004-08-02 2006-02-02 Waters Wade R Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis
WO2007037706A2 (en) 2005-09-27 2007-04-05 Bernd Helmut Adam Rehm Polymer particles and uses thereof
KR20140015127A (ko) 2009-07-29 2014-02-06 베른드 헬무트 아담 렘 폴리머 입자 및 이의 용도
WO2012104791A1 (en) 2011-02-01 2012-08-09 Bernd Helmut Adam Rehm Fusion polypeptides and uses thereof
WO2014009439A1 (en) 2012-07-10 2014-01-16 Nec Europe Ltd. Reporting user related information in a mobile communication network

Also Published As

Publication number Publication date
EP3102613B1 (en) 2021-06-09
PL3102613T3 (pl) 2021-12-13
SI3102613T1 (sl) 2021-11-30
ES2891973T3 (es) 2022-02-01
HUE056108T2 (hu) 2022-01-28
HK1232241A1 (zh) 2018-01-05
EP3102613A1 (en) 2016-12-14
US10501505B2 (en) 2019-12-10
LT3102613T (lt) 2021-09-27
HRP20211418T1 (hr) 2021-12-24
DK3102613T3 (da) 2021-09-13
CY1124491T1 (el) 2022-07-22
WO2015119512A1 (en) 2015-08-13
EP3102613A4 (en) 2017-12-20
US20170008938A1 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
IL249186A0 (en) Anti-cd20 glycoantibodies and their uses
HK1231471A1 (zh) -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途
IL247344B (en) A new polysaccharide and its uses
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
GB201405614D0 (en) Particles
HUE044571T2 (hu) Módosított ciklopentapeptidek és alkalmazásaik
GB201512725D0 (en) Polymeric particles
HK1232241A1 (zh) 聚合物顆粒及其用途
EP3192815A4 (en) High-recoverability resin particles and use thereof
SG11201607082PA (en) New tetracyano-anthraquino-dimethane polymers and use thereof
EP3357934B8 (en) Polymer particles and use thereof
GB201503393D0 (en) Polymers and uses thereof
SG11201704473WA (en) New methods and uses
GB201412841D0 (en) Particles
EP3168250A4 (en) Fluorine-atom-containing polymer and use thereof
IL248014B (en) Nanostructures and their applications
EP3229842A4 (en) Lipocationic polymers and uses thereof
GB2543713B (en) Polymeric proteins and uses thereof
GB201408091D0 (en) Methods and uses
IL251518A0 (en) Astaxanthin-based polymers and their uses
SG10201501373WA (en) Contrast Agent And Applications Thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
PT2923578T (pt) Método para a produção de um produto alimentar
GB201416086D0 (en) Methods and uses
GB201416073D0 (en) Methods and uses